PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
20-May-2025 Another Day Pharma announces promising Phase II results for topical post-prostatectomy erectile dysfunction treatment Another Day Pharma Ltd
20-May-2025 Kanceraprovides an update on the collaboration with Recardio Inc. and the company’s clinical development program Kancera
20-May-2025 Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock AdrenoMed AG
20-May-2025 Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock Adrenomed AG
20-May-2025 First Patient Randomized in Jaguar Health's Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Crofelemer in Pediatric Patients with Microvillus Inclusion Disease (MVID) ACCESS Newswire
20-May-2025 Petros Pharmaceuticals Partners with Innolitics, a Leading Software-as-a-Medical-Device Developer ACCESS Newswire
20-May-2025 Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 ACCESS Newswire
20-May-2025 ZetrOZ Systems' sam(R) Wearable Ultrasound Helps Osteoarthritis Patients Return to Regular Activities ACCESS Newswire
20-May-2025 Harmony Healthcare, an Addison Group Company, Celebrates 15 Years of Empowering Healthcare Organizations ACCESS Newswire
20-May-2025 Cambridge Isotope Laboratories Launches ISOLED-D: Revolutionary Deuterated Reagents for OLED Manufacturing ACCESS Newswire
20-May-2025 Fabry Disease Treatment Market Expected to Reach USD 5.1 Million by 2034 Global Market Insights, Inc.
20-May-2025 Alligator Bioscience Announces Paediatric Study Waiver for Mitazalimab Granted by the European Medicines Agency ACCESS Newswire
20-May-2025 Cold Plasma Wound Treatment Market is estimated to be $400 Million in 2025 and is growing at 12% as Chronic Wound Cases Surge Globally globenewswireonlione
20-May-2025 Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation ACCESS Newswire
20-May-2025 Iraq's First Fully Solar-Powered Village in Kulak Is Now Operational ACCESS Newswire
20-May-2025 Hear At Last Holdings Receives Initial Purchase Order of Portable Homes from Jamaican Developer ACCESS Newswire
20-May-2025 BRAIN Biotech announces buy-out of minorities, new continental European production site, and expansion of its Baking Application Center BRAIN Biotech AG
20-May-2025 Interactive Strength Inc. (Nasdaq:TRNR) Reiterates $75M Guidance, Expected Profitability in Q4 on Adjusted EBITDA Basis Due to Pending Sportstech, Wattbike Deals ACCESS Newswire
20-May-2025 Buy Semaglutide Online: SEMA BIO ACCESS Newswire
20-May-2025 Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis ACCESS Newswire